This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Axcelead Drug Discovery Partners


Axcelead Drug Discovery Partners is Japan’s first drug discovery solution provider established in July 2017 by taking over the drug discovery platform from Takeda Pharmaceutical. Screening, Medicinal chemistry, Pharmacology / Biology, DMPK, and Safety research functions are integrated into one center with a state-of-the-art research base and original compound library. This enables Axcelead to create drug candidates by utilizing the vast amount of past drug discovery research data. By leveraging these strengths, we provide solutions to various challenges faced in the process from exploratory research to clinical in drug discovery.